Examine Case Study: An Elderly Iranian Man With Alzheimer’s Disease. You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client’s pharmacokinetic and pharmacodynamic processes.

• At each decision point stop to complete the following:

• Decision #1
  • Which decision did you select?
  • Why did you select this decision? Support your response with evidence and references to the Learning Resources.
  • What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
  • Explain any difference between what you expected to achieve with Decision #1 and the results of the decision. Why were they different?

• Decision #2
  • Why did you select this decision? Support your response with evidence and references to the Learning Resources.
  • What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
  • Explain any difference between what you expected to achieve with Decision #2 and the results of the decision. Why were they different?

• Decision #3
  • Why did you select this decision? Support your response with evidence and references to the Learning Resources.
  • What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
  • Explain any difference between what you expected to achieve with Decision #3 and the results of the decision. Why were they different?

Also include how ethical considerations might impact your treatment plan and communication with clients.

Solution:

Assessing and Treating Patients with Dementia

The most common cause of dementia is Alzheimer’s disease (AD) (also referred to a neurocognitive disorder) as it results to approximately 60 to 80 percents to all cases of dementia (Wu et al., 2017). The prevalence of AD cases is estimated to be 5.5 million adults within the United States and about 35 million people globally (Wu et al., 2017). According to Prince, Ali, Guerchet, Prina, Albanese, and Wu (2016), the US registers one case of AD every 66 seconds and this is projected to worsen to one AD case every 33 seconds by 2050, totaling up to 1 million new cases every year. As defined by Wu et al. (2017), dementia is a chronic and lasting deterioration of cognitive functioning which may transpire at any age. However, it is more common among the elderly aged 65 years and above who account for more than 50% of total admissions to nursing homes (Prince et al., 2016). This paper is aimed at assessing and treating a 76-year-old Iranian male who presents with symptoms of dementia whilst taking into cognizance the patient’s pharmacokinetics and pharmacodynamic factors. The paper also includes ethical considerations in the treatment of dementia……Please click the icon below to purchase full solution at $10